T. Rowe Price Associates’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-510,156
| Closed | -$67.3M | – | 2580 |
|
|
2018
Q4 | $67.3M | Sell |
510,156
-851,043
| -63% | -$112M | 0.01% | 710 |
|
|
2018
Q3 | $182M | Sell |
1,361,199
-1,464,173
| -52% | -$196M | 0.03% | 511 |
|
|
2018
Q2 | $450M | Sell |
2,825,372
-835,209
| -23% | -$133M | 0.07% | 277 |
|
|
2018
Q1 | $524M | Buy |
3,660,581
+206,322
| +6% | +$29.5M | 0.08% | 245 |
|
|
2017
Q4 | $460M | Buy |
3,454,259
+458,393
| +15% | +$61M | 0.07% | 273 |
|
|
2017
Q3 | $373M | Sell |
2,995,866
-121,173
| -4% | -$15.1M | 0.06% | 314 |
|
|
2017
Q2 | $438M | Sell |
3,117,039
-645,517
| -17% | -$90.7M | 0.08% | 268 |
|
|
2017
Q1 | $424M | Buy |
3,762,556
+1,953,680
| +108% | +$220M | 0.08% | 265 |
|
|
2016
Q4 | $190M | Sell |
1,808,876
-822,370
| -31% | -$86.5M | 0.04% | 432 |
|
|
2016
Q3 | $332M | Buy |
2,631,246
+9,567
| +0.4% | +$1.21M | 0.07% | 293 |
|
|
2016
Q2 | $362M | Sell |
2,621,679
-160,268
| -6% | -$22.1M | 0.08% | 279 |
|
|
2016
Q1 | $386M | Buy |
2,781,947
+232,425
| +9% | +$32.3M | 0.08% | 266 |
|
|
2015
Q4 | $410M | Sell |
2,549,522
-413,962
| -14% | -$66.6M | 0.09% | 249 |
|
|
2015
Q3 | $395M | Buy |
2,963,484
+582,445
| +24% | +$77.7M | 0.09% | 252 |
|
|
2015
Q2 | $273M | Buy |
2,381,039
+398,467
| +20% | +$45.7M | 0.06% | 368 |
|
|
2015
Q1 | $237M | Buy |
1,982,572
+4,724
| +0.2% | +$564K | 0.05% | 400 |
|
|
2014
Q4 | $288M | Sell |
1,977,848
-240,084
| -11% | -$35M | 0.06% | 354 |
|
|
2014
Q3 | $292M | Sell |
2,217,932
-734,353
| -25% | -$96.7M | 0.06% | 339 |
|
|
2014
Q2 | $369M | Buy |
2,952,285
+799,642
| +37% | +$100M | 0.08% | 297 |
|
|
2014
Q1 | $345M | Sell |
2,152,643
-64,672
| -3% | -$10.4M | 0.08% | 299 |
|
|
2013
Q4 | $298M | Sell |
2,217,315
-150,000
| -6% | -$20.2M | 0.07% | 331 |
|
|
2013
Q3 | $257M | Sell |
2,367,315
-100,000
| -4% | -$10.9M | 0.06% | 349 |
|
|
2013
Q2 | $209M | Buy |
+2,467,315
| New | +$209M | 0.06% | 378 |
|